PHVS

PHVS

USD

Pharvaris N.V. Ordinary Shares

$21.640-0.842 (-3.746%)

即時價格

Healthcare
生物科技
瑞士

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$22.482

最高

$22.482

最低

$21.585

交易量

0.14M

公司基本面

市值

1.4B

行業

生物科技

國家

Switzerland

交易統計

平均交易量

0.19M

交易所

NMS

貨幣

USD

52週範圍

最低 $11.51當前 $21.640最高 $26.33

相關新聞

GlobeNewswire

Pharvaris to Present Clinical Data at the ACAAI 2025 Annual Scientific Meeting

ZUG, Switzerland, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Pharvaris (NASDAQ:PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living

查看更多
Pharvaris to Present Clinical Data at the ACAAI 2025 Annual Scientific Meeting
Analyst Upgrades

HC Wainwright & Co. Initiates Coverage On Pharvaris with Buy Rating, Announces Price Target of $60

HC Wainwright & Co. analyst Patrick R. Trucchio initiates coverage on Pharvaris with a Buy rating and announces Price Target of $60.

查看更多
HC Wainwright & Co. Initiates Coverage On Pharvaris with Buy Rating, Announces Price Target of $60
Analyst Upgrades

B of A Securities Upgrades Pharvaris to Neutral, Raises Price Target to $27

B of A Securities analyst Tazeen Ahmad upgrades Pharvaris from Underperform to Neutral and raises the price target from $16 to $27.

查看更多
B of A Securities Upgrades Pharvaris to Neutral, Raises Price Target to $27